{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:06:57Z","timestamp":1771466817661,"version":"3.50.1"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T00:00:00Z","timestamp":1424131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0118028","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T18:55:11Z","timestamp":1424199311000},"page":"e0118028","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Impediments to Enhancement of CPT-11 Anticancer Activity by E. coli Directed Beta-Glucuronidase Therapy"],"prefix":"10.1371","volume":"10","author":[{"given":"Yuan-Ting","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Chuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiu-Min","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Lu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi-Hua","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve R.","family":"Roffler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,2,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0065-2660(10)69015-3","article-title":"Strategies for targeting tumors and tumor vasculature for cancer therapy","volume":"69","author":"P Sreeramoju","year":"2010","journal-title":"Adv Genet"},{"key":"ref2","first-page":"3314","article-title":"Strategies for enzyme\/prodrug cancer therapy","volume":"7","author":"G Xu","year":"2001","journal-title":"Clin Cancer Res"},{"key":"ref3","first-page":"2662","article-title":"Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954","volume":"7","author":"G Chung-Faye","year":"2001","journal-title":"Clin Cancer Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cgt.2011.3","article-title":"Enhancement of CPT-11 antitumor activity by adenovirus-mediated expression of beta-glucuronidase in tumors","volume":"18","author":"PT Huang","year":"2011","journal-title":"Cancer Gene Ther"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1023\/A:1022608321861","article-title":"Liposome-mediated targeting of enzymes to cancer cells for site-specific activation of prodrugs: comparison with the corresponding antibody-enzyme conjugate","volume":"20","author":"MJ Fonseca","year":"2003","journal-title":"Pharm Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1021\/bc1005784","article-title":"A humanized immunoenzyme with enhanced activity for glucuronide prodrug activation in the tumor microenvironment","volume":"22","author":"KC Chen","year":"2011","journal-title":"Bioconjug Chem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0169-409X(97)00032-X","article-title":"Antibody-directed enzyme prodrug therapy (ADEPT): a review","volume":"26","author":"CJ Springer","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrc2934","article-title":"Engineering the perfect (bacterial) cancer therapy","volume":"10","author":"NS Forbes","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"ref9","first-page":"473","article-title":"Localization of the vegetative form of Clostridium tetani in mouse tumors following intravenous spore administration","volume":"15","author":"RA Malmgren","year":"1955","journal-title":"Cancer Res"},{"key":"ref10","first-page":"212","article-title":"Oncolysis by Clostridia. I. Activity of Clostridium Butyricum (M-55) and Other Nonpathogenic Clostridia against the Ehrlich Carcinoma","volume":"24","author":"JR Moese","year":"1964","journal-title":"Cancer Res"},{"key":"ref11","first-page":"2061","article-title":"Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration","volume":"40","author":"NT Kimura","year":"1980","journal-title":"Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.cgt.7700122","article-title":"Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors","volume":"7","author":"K Yazawa","year":"2000","journal-title":"Cancer Gene Ther"},{"key":"ref13","first-page":"4537","article-title":"Tumor-targeted Salmonella as a novel anticancer vector","volume":"57","author":"JM Pawelek","year":"1997","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1086\/315497","article-title":"Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium","volume":"181","author":"C Clairmont","year":"2000","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/cgt.2008.10","article-title":"Tumor-targeting prodrug-activating bacteria for cancer therapy","volume":"15","author":"CM Cheng","year":"2008","journal-title":"Cancer Gene Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nbt937","article-title":"Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins","volume":"22","author":"YA Yu","year":"2004","journal-title":"Nat Biotechnol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/cgt.2009.76","article-title":"Tumor-targeted delivery of biologically active TRAIL protein","volume":"17","author":"HY Zhang","journal-title":"Cancer Gene Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijmm.2007.01.008","article-title":"Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice","volume":"297","author":"J Stritzker","year":"2007","journal-title":"Int J Med Microbiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11307-007-0120-5","article-title":"Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli","volume":"10","author":"JJ Min","year":"2008","journal-title":"Mol Imaging Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/mt.2009.295","article-title":"Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy","volume":"18","author":"SN Jiang","journal-title":"Mol Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJM199310213291702","article-title":"Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support","volume":"329","author":"OW Press","year":"1993","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1158\/1078-0432.CCR-10-1654","article-title":"Evaluation of the anti-HER2 C6.5 diabody as a PET radiotracer to monitor HER2 status and predict response to trastuzumab treatment","volume":"17","author":"S Reddy","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1158\/1535-7163.MCT-13-0383","article-title":"Cytoreductive chemotherapy improves the biodistribution of antibodies directed against tumor necrosis in murine solid tumor models","volume":"12","author":"JK Jang","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/protein\/gzu013","article-title":"Tumor-targeting properties of novel immunocytokines based on murine IL1beta and IL6","volume":"27","author":"C Hess","year":"2014","journal-title":"Protein Eng Des Sel"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e83239","DOI":"10.1371\/journal.pone.0083239","article-title":"Peptide-mediated liposomal Doxorubicin enhances drug delivery efficiency and therapeutic efficacy in animal models","volume":"8","author":"DK Chang","year":"2013","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1021\/mp400759d","article-title":"Development of Synthetic Peptide-Modified Liposomes with LDL Receptor Targeting Capacity and Improved Anticancer Activity","volume":"11","author":"M Liu","year":"2014","journal-title":"Mol Pharm"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1021\/nn405839n","article-title":"Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes","volume":"8","author":"HS Qhattal","year":"2014","journal-title":"ACS Nano"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jconrel.2014.03.043","article-title":"Phosphatidylserine-targeted bimodal liposomal nanoparticles for in vivo imaging of breast cancer in mice","volume":"183","author":"L Zhang","year":"2014","journal-title":"J Control Release"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/13543770902773437","article-title":"Novel camptothecin derivatives as topoisomerase I inhibitors","volume":"19","author":"S Basili","year":"2009","journal-title":"Expert Opin Ther Pat"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0006-2952(96)00457-1","article-title":"Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase","volume":"52","author":"LP Rivory","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"ref31","first-page":"4187","article-title":"Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11","volume":"51","author":"Y Kawato","year":"1991","journal-title":"Cancer Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"15387","DOI":"10.1073\/pnas.242259599","article-title":"The mechanism of topoisomerase I poisoning by a camptothecin analog","volume":"99","author":"BL Staker","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1172\/JCI915","article-title":"Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes","volume":"101","author":"L Iyer","year":"1998","journal-title":"J Clin Invest"},{"key":"ref34","first-page":"1261","article-title":"Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I\/II trials","volume":"3","author":"LP Rivory","year":"1997","journal-title":"Clin Cancer Res"},{"key":"ref35","first-page":"2182","article-title":"Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)","volume":"7","author":"RH Mathijssen","year":"2001","journal-title":"Clin Cancer Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.cgt.7700999","article-title":"Membrane-localized activation of glucuronide prodrugs by beta-glucuronidase enzymes","volume":"14","author":"KC Chen","year":"2007","journal-title":"Cancer Gene Ther"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1158\/1535-7163.MCT-08-0812","article-title":"Local enzymatic hydrolysis of an endogenously generated metabolite can enhance CPT-11 anticancer efficacy","volume":"8","author":"ZM Prijovich","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1158\/0008-5472.CAN-07-2984","article-title":"Containment of tumor-colonizing bacteria by host neutrophils","volume":"68","author":"K Westphal","year":"2008","journal-title":"Cancer Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1128\/JB.181.16.5060-5067.1999","article-title":"Functional and transcriptional analyses of a fengycin synthetase gene, fenC, from Bacillus subtilis","volume":"181","author":"TP Lin","year":"1999","journal-title":"J Bacteriol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/protein\/gzs033","article-title":"ECSTASY, an adjustable membrane-tethered\/soluble protein expression system for the directed evolution of mammalian proteins","volume":"25","author":"CP Chen","year":"2012","journal-title":"Protein Eng Des Sel"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1165\/ajrcmb.17.3.2837","article-title":"Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line","volume":"17","author":"YW Chu","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s002620050387","article-title":"Poly(ethylene glycol) modification of beta-glucuronidase-antibody conjugates for solid-tumor therapy by targeted activation of glucuronide prodrugs","volume":"44","author":"TL Cheng","year":"1997","journal-title":"Cancer Immunol Immunother"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1021\/bc980143z","article-title":"Accelerated clearance of polyethylene glycol-modified proteins by anti-polyethylene glycol IgM","volume":"10","author":"TL Cheng","year":"1999","journal-title":"Bioconjug Chem"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1042\/BA20030184","article-title":"A simple method for the production of recombinant proteins from mammalian cells","volume":"40","author":"CH Wu","year":"2004","journal-title":"Biotechnol Appl Biochem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/sj.gt.3302671","article-title":"A membrane antibody receptor for noninvasive imaging of gene expression","volume":"13","author":"SR Roffler","year":"2006","journal-title":"Gene Ther"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/JB.120.1.89-95.1974","article-title":"Inducibility of beta-glucuronidase in wild-type and hexuronate-negative mutants of Escherichia coli K-12","volume":"120","author":"G Novel","year":"1974","journal-title":"J Bacteriol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cgt.2011.3","article-title":"Enhancement of CPT-11 antitumor activity by adenovirus-mediated expression of beta-glucuronidase in tumors","volume":"18","author":"PT Huang","journal-title":"Cancer Gene Ther"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2013.05.005","article-title":"Bacterial-directed enzyme prodrug therapy","volume":"170","author":"P Lehouritis","year":"2013","journal-title":"J Control Release"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.micinf.2009.08.002","article-title":"Drug-inducible remote control of gene expression by probiotic Escherichia coli Nissle 1917 in intestine, tumor and gall bladder of mice","volume":"11","author":"H Loessner","year":"2009","journal-title":"Microbes Infect"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/cgt.2009.76","article-title":"Tumor-targeted delivery of biologically active TRAIL protein","volume":"17","author":"HY Zhang","year":"2010","journal-title":"Cancer Gene Ther"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/mt.2014.23","article-title":"Bacterial-mediated knockdown of tumor resistance to an oncolytic virus enhances therapy","volume":"22","author":"M Cronin","year":"2014","journal-title":"Mol Ther"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/sj.gt.3302281","article-title":"Potential therapeutic applications of recombinant, invasive E. coli","volume":"11","author":"RJ Critchley","year":"2004","journal-title":"Gene Ther"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1046\/j.1365-2672.2000.01211.x","article-title":"An investigation into the pathogenic properties of Escherichia coli strains BLR, BL21, DH5alpha and EQ1","volume":"89","author":"H Chart","year":"2000","journal-title":"J Appl Microbiol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1128\/JB.187.7.2377-2385.2005","article-title":"The gusBC genes of Escherichia coli encode a glucuronide transport system","volume":"187","author":"WJ Liang","year":"2005","journal-title":"J Bacteriol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/cgt.2013.17","article-title":"Expression of beta-glucuronidase on the surface of bacteria enhances activation of glucuronide prodrugs","volume":"20","author":"CM Cheng","year":"2013","journal-title":"Cancer Gene Ther"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/nrc1456","article-title":"High interstitial fluid pressure\u2014an obstacle in cancer therapy","volume":"4","author":"CH Heldin","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"e40006","DOI":"10.1371\/journal.pone.0040006","article-title":"High interstitial fluid pressure is associated with tumor-line specific vascular abnormalities in human melanoma xenografts","volume":"7","author":"TG Simonsen","year":"2012","journal-title":"PLoS One"},{"key":"ref58","first-page":"4478","article-title":"Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy","volume":"50","author":"Y Boucher","year":"1990","journal-title":"Cancer Res"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"e36258","DOI":"10.1371\/journal.pone.0036258","article-title":"High interstitial fluid pressure is associated with low tumour penetration of diagnostic monoclonal antibodies applied for molecular imaging purposes","volume":"7","author":"M Heine","year":"2012","journal-title":"PLoS One"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrc1893","article-title":"Drug penetration in solid tumours","volume":"6","author":"AI Minchinton","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"12879","DOI":"10.1073\/pnas.0701959104","article-title":"Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth","volume":"104","author":"M Loeffler","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"7995","DOI":"10.1158\/0008-5472.CAN-08-1698","article-title":"Optimized clostridium-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA cross-linking agent PR-104","volume":"68","author":"SC Liu","year":"2008","journal-title":"Cancer Res"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00262-008-0555-9","article-title":"Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth","volume":"58","author":"M Loeffler","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/mt.2009.295","article-title":"Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy","volume":"18","author":"SN Jiang","year":"2010","journal-title":"Mol Ther"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1038\/mt.2013.183","article-title":"Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent","volume":"21","author":"SN Jiang","year":"2013","journal-title":"Mol Ther"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"e80050","DOI":"10.1371\/journal.pone.0080050","article-title":"Anti-tumoral effect of the mitochondrial target domain of Noxa delivered by an engineered Salmonella typhimurium","volume":"9","author":"JH Jeong","year":"2014","journal-title":"PLoS One"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1158\/1078-0432.CCR-07-4800","article-title":"Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy","volume":"14","author":"F Friedlos","year":"2008","journal-title":"Clin Cancer Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0118028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T02:45:01Z","timestamp":1598755501000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0118028"}},"subtitle":[],"editor":[{"given":"Patrick C.","family":"Cirino","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,2,17]]},"references-count":67,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,2,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0118028","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,17]]}}}